Epigenetics, mismatch repair genes and colorectal cancer

Annals of the Royal College of Surgeons of England

Volumn 87, Issue 1, 2005, Pages 15-20

  Wheeler, James M D ^a,b  

^a JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^b CHELTENHAM GENERAL HOSPITAL   (United Kingdom)

Author keywords

Colorectal cancer; Epigenetics; Hypermethylation; Mismatch repair genes; Replication error

Indexed keywords

CELL DNA; PROTEIN MLH1; UVOMORULIN;

ARTICLE; COLORECTAL ADENOMA; COLORECTAL CANCER; COLORECTAL CARCINOMA; CORRELATION ANALYSIS; DNA METHYLATION; DNA REPLICATION; EPIGENETICS; FREQUENCY ANALYSIS; GENE EXPRESSION; GENE FUNCTION; GENE INACTIVATION; GENE MUTATION; HUMAN; MISMATCH REPAIR; PHENOTYPE; PROMOTER REGION; PROTEIN DEPLETION; TUMOR SUPPRESSOR GENE;

ADENOCARCINOMA; BASE PAIR MISMATCH; CADHERINS; CARRIER PROTEINS; COLORECTAL NEOPLASMS; DNA METHYLATION; DNA REPAIR; DNA REPLICATION; HUMANS; MICROSATELLITE REPEATS; MIDDLE AGED; NEOPLASM PROTEINS; NUCLEAR PROTEINS; PROMOTER REGIONS (GENETICS);

EID: 12144280302     PISSN: 00358843     EISSN: None     Source Type: Journal    
DOI: 10.1308/1478708051423     Document Type: Article

References (32)

1. Wheeler JMD, Bodmer WF, Mortensen NJMcC. DNA mismatch repair genes and colorectal cancer. Gut 2000; 47: 148-53.
2. Vasen HF, Mecklin JP, Khan PM, Lynch HT. The International Collaborative Group on Hereditary Non-Polyposis Colorectal Cancer (ICG-HNPCC). Dis Colon Rectum 1991; 34: 424-5.
3. Vasen HFA, Watson P, Mecklin JP, Lynch HT. New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative Group on HNPCC. Gastroenterology 1999; 116: 1453-6.
4. Aaltonen LA, Peltomaki P, Leach FS, Sistonen F, Pylkkanen L, Mecklin JP et al. Clues to the pathogenesis of familial colorectal cancer. Science 1993; 260: 812-6.
5. Fishel R, Lescoe MK, Rao MR, Copeland NG, Jenkins NA, Garber J et al. The human mutator gene homolog MSH2 and its association with hereditary nonpolyposis colon cancer. Cell 1993; 75: 1027-38.
6. Leach FS, Nicolaides NC, Papadopoulos N, Liu B, Jen J, Parsons R et al. Mutations of a mutS homolog in hereditary nonpolyposis colorectal cancer. Cell 1993; 75:1215-25.
7. Bronner CE, Baker SM, Morrison PT, Warren G, Smith LG, Lescoe MK et al. Mutation in the DNA mismatch repair gene homologue hMLH1 is associated with hereditary non-polyposis colon cancer. Nature 1994; 368: 258-61.
8. Papadopoulos N, Nicolaides NC, Wei YF, Ruben SM, Carter KC, Rosen CA et al. Mutation of a mutL homolog in hereditary colon cancer. Science 1994; 263: 1625-9.
9. Aaltonen LA, Salovaara R, Kristo P, Canzian F, Hemminki A, Peltomaki P et al. Incidence of hereditary nonpolyposis colorectal cancer and the feasibility of molecular screening for the disease. N Engl J Med 1998; 338: 1481-7.
10. Knudson Jr AG. Mutation and cancer: statistical study of retinoblastoma. Proc Natl Acad Sci USA 1971; 68: 820-3.
11. Liu B, Nicolaides NC, Markowitz S, Willson JK, Parsons RE, Jen J et al. Mismatch repair gene defects in sporadic colorectal cancers with microsatellite instability. Nat Genet 1995; 9: 48-55.
12. Thibodeau SN, French AJ, Cunningham JM, Tester D, Burgart LJ, Roche PC et al. Microsatellite instability in colorectal cancer: different mutator phenotypes and the principal involvement of hMLH1. Cancer Res 1998; 58: 1713-8.
13. Jones PA, Laird PW. Cancer epigenetics comes of age. Nat Genet 1999; 21: 163-7.
14. Herman JG, Latif F, Weng Y, Lerman MI, Zbar B, Liu S et al. Silencing of the VHL tumor-suppressor gene by DNA methylation in renal carcinoma. Proc Natl Acad Sci USA 1994; 91: 9700-4.
15. Herman JG, Merlo A, Mao L, Lapidus RG, Issa JP, Davidson NE et al. Inactivation of the CDKN2/p16/MTS1 gene is frequently associated with aberrant DNA methylation in all common human cancers. Cancer Res 1995; 55: 4525-30.
16. Merlo A, Herman JG, Mao L, Lee DJ, Gabrielson E, Burger PC et al. 5′ CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/CDKN2/MTS1 in human cancers. Nat Med 1995; 1: 686-92.
17. Ahuja N, Mohan AL, Li Q, Stolker JM, Herman JG, Hamilton SR et al. Association between CpG island methylation and microsatellite instability in colorectal cancer. Cancer Res 1997; 57: 3370-4.
18. Kane MF, Loda M, Gaida GM, Lipman J, Mishra R, Goldman H et al. Methylation of the hMLH1 promoter correlates with lack of expression of hMLH1 in sporadic colon tumors and mismatch repair-defective human tumor cell lines. Cancer Res 1997; 57: 808-11.
19. Wheeler JMD, Beck NE, Kim HC, Tomlinson IPM, Mortensen NJM, Bodmer WF. Mechanisms of inactivation of mismatch repair genes in human colorectal cancer cell lines: the predominant role of hMLH1. Proc Natl Acad Sci USA 1999; 96: 10296-301.
20. Herman JG, Umar A, Polyak K, Graff JR, Ahuja N, Issa JP et al. Incidence and functional consequences of hMLH1 promoter hypermethylation in colorectal carcinoma. Proc Natl Acad Sci USA 1998; 95: 6870-5.
21. + colorectal cancers. J Med Genet 2000; 37 588-92.
22. Toyota M, Ohe-Toyota M, Ahuja N, Issa JP. Distinct genetic profiles in colorectal tumours with or without the CpG island methylator phenotype. Proc Natl Acad Sci USA 2000; 97: 710-5.
23. Yamamoto H, Min Y, Itoh F, Imsumran A, Horiuchi S, Yoshida M et al. Differential involvement of the hypermethylator phenotype in hereditary and sporadic colorectal cancers with high-frequency microsatellite instability. Genes Chromosom Cancer 2002, 33: 322-5.
24. Homfray TF, Cottrell SE, Ilyas M, Rowan A, Talbot IC, Bodmer WF et al. Defects in mismatch repair occur after APC mutations in the pathogenesis of sporadic colorectal tumours. Hum Mutat 1998; 11: 114-20.
25. Efsthathiou JA, Liu D, Wheeler JMD, Kim HC, Beck NE, Ilyas M et al. Mutated E-cadherin is associated with increased tumorigenicity, loss of adhesion and of responsiveness to the mitogenic trefoil factor 2 in colon carcinoma cells. Proc Natl Acad Sci USA 1999; 96: 2316-21.
26. Wheeler JMD, Kim HC, Efstathiou JA, Ilyas M, Mortensen NJMcC, Bodmer WF. Hypermethylation of the promoter region of the E-cadherin gene (CDH1) in sporadic and ulcerative colitis associated colorectal cancer. Gut 2001; 48: 367-71.
27. Azarschab F, Porschen R, Gregor M, Blin N, Holzmann. Epigenetic control of the E-cadherin gene (CDH1) by CpG methylation in colectomy samples of patients with ulcerative colitis. Genes Chromosom Cancer 2002, 35: 121-6.
28. Simpkins SB, Bocker T, Swisher EM, Mutch DG, Gersell DJ, Kovatich AJ et al. MLH1 promoter methylation and gene silencing is the primary cause of microsatellite instability in sporadic endometrial cancers. Hum Mol Genet 1999; 8: 661-6.
29. Leung SY, Yuen ST, Chung LP, Chu KM, Chan AS, Ho JC. hMLH1 promoter methylation and lack of hMLH1 expression in sporadic gastric carcinomas with high-frequency microsatellite instability. Cancer Res 1999; 59: 159-64.
30. Wheeler JMD, Warren BF, Mortensen NJMcC, Williams GT, Shepherd NA, Bateman AC et al. An insight into the genetic pathway of adenocarcinoma of the small intestine. Gut 2002; 50: 218-23.
31. Estetler M, Sparks A, Toyota M, Sanchez-Cespedes M, Capella G, Peinado MA et al. Analysis of adenomatous polyposis coli promoter hypermethylation in human cancer. Cancer Res 2000; 60 4366-71.
32. Plumb JA, Strathdee G, Sludden J, Kaye SB, Brown R. Reversal of drug resistance in human tumour xenografts by 2′-deoxy-5-azacytidine-induced demethylation of the hMLH1 gene promoter. Cancer Res 2000; 60: 6039-44.